Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion type Assertion NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_head.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion evidence source_evidence_literature NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion SIO_000772 11919393 NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion wasDerivedFrom befree-2016 NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.
- NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion wasGeneratedBy ECO_0000203 NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.